Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance Therapy

Clinical trial NCT00691704 · COMPLETED

Trial details

NCT number: NCT00691704
Sponsor: Cristina Gasparetto
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2008-08-01
Primary completion: 2012-12-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.